IRCT201609105563N8招募中2 期
Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometrioma
Vice chancellor for Research,Tabriz University Of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 45 years（—）
- 性别
- Female
入选标准
- •womens aged 15-45; unilateral endometrioma, endometrioma diagnosis with ultrasound; CA 125<100; mass size less than or equal to 6 cm
- •Exclusion criteria:
- •the possibility of malignancy; contraindications of LD pill; ischemic heart disease or previous history of it; current breast cancer; liver tumors (benign and malignant))
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluation of the effectiveness of platelet-rich plasma in the treatment of Asherman's syndromeAsherman syndrome.Intrauterine synechiaeN85.6IRCT20200316046789N1Esfahan University of Medical Sciences60
Unknown
不适用
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot FlashesHot FlashesNight SweatsNCT00547001Hartford Hospital235
已完成
3 期
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric statesIRCT138809032766N1Tarbiat Maodares University150
进行中（未招募）
不适用
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI
进行中（未招募）
不适用
Effets du traitement hormonal substitutif et du raloxifène sur les cellules dendritiques plasmacytoïdes et les lymphocytes B chez les femmes ménopausées - EstrimmuneMenopauseEUCTR2009-017144-14-FRCentre Hospitalier de Toulouse